150 Chapter 5 At the end of the fellowship the participants were asked to provide a full case video to evaluate by certified independent examiners in blind-review process. A total of 28 (62%) handed in an index video for review, of these only 12 (43%) received a score from the experts. All respondents would recommend the CC-ERUS fellowship to their colleagues. The results in table 2 show the activities of the respondents after their clinical fellowship. Less than half of the fellows were able to stay in the institute of their training after the fellowship. After the fellowship 93% of the respondents had access to a Table 2 Activities of the respondents during and after their clinical fellowship Number of participants % Number of participants who stayed in their training institute after the fellowship No 23 51.1 Yes, less than 3 months 1 2.2 Yes, more than 3 months 21 46.7 Number of participants who had access to a surgical robot after the fellowship 42 93.3 Currently performing robot assisted surgery 41 91.1 Currently performing RARP 39 86.7 Currently performing RARC 16 35.6 Currently performing RAPN 19 42.2 Currently performing Laparoscopic prostatectomy 5 11.1 Currently performing Open prostatectomy 8 17.8 surgical robot, of these 91% are currently still performing robot assisted surgery. Thirty-nine respondents (91%) are performing RARP surgery, 16 (36%) are performing RARC and 19 (42%) are performing RAPN surgery. A minority of the respondents are performing open (18%) or laparoscopic prostatectomy (11%). Table 3 shows the functional and oncological outcomes of the most recent surgeries performed by the fellows involved in the CC-ERUS RARP fellowship. More than 50% of the participants to the fellowship are unaware of the continence and erectile function recovery of the patients treated in the last six months. The participants were more aware of the positive surgical margins in their last 10 pT2 and pT3 patients (Table 3).